http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2567039-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3278c1964f8df0b8050a9d85de0cc5c7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a1bd50b17de1e24ccad3b281dbdf03c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d2a527b7d92491056607ac2a23e756e |
| publicationDate | 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2567039-C1 |
| titleOfInvention | Method for assessing foetal development threat caused by aggravated cytomegaloviral infection in the first trimester of gestation, inducing decrease of dehydroepiandrosterone sulphate and oestriol synthesis |
| abstract | FIELD: medicine. n SUBSTANCE: method involves analysing peripheral blood to measure an anti-cytomegalovirus antibody titre in the first trimester of gestation, placental homogenate dehydroepiandrosteron sulphate when the patient is 12 weeks pregnant and peripheral blood dehydroepiandrosteron sulphate and oestriol. If the anti-cytomegalovirus antibody titre tends to increase to 1:1,600, placental homogenate dehydroepiandrosteron sulphate grows to 1.20 mcmole/l, and peripheral blood dehydroepiandrosteron sulphate decreases to 7.53 mcmole/l, and oestriol - to 2.70 pmole/l, a foetal development threat is stated. n EFFECT: higher accuracy of assessment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2582967-C1 |
| priorityDate | 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.